Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma.
about
The role of HPV in head and neck cancer and review of the HPV vaccineTargeted Therapy in Oropharyngeal Squamous Cell Carcinoma: The Implications of HPV for TherapyHPV in oropharyngeal cancer: the basics to know in clinical practiceHuman papilloma virus infection in head and neck cancerLessons learned from next-generation sequencing in head and neck cancerIs radiation dose reduction the right answer for HPV-positive head and neck cancer?Clinical features and treatment strategy for HPV-related oropharyngeal cancer.Management of locally advanced HPV-related oropharyngeal squamous cell carcinoma: where are we?Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus.Human papilloma virus in squamous carcinoma of the head and neck: a study of cases in south east Scotland.Reduced impact of nodal metastases as a prognostic factor for tonsil cancer in the HPV eraMMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer.Advances and Perspectives in the Molecular Diagnosis of Head and Neck Cancer.HPV-related nonkeratinizing squamous cell carcinoma of the oropharynx: utility of microscopic features in predicting patient outcome.Human Papilloma Virus (HPV) in head and neck region: review of literature.Tobacco use in human papillomavirus-positive advanced oropharynx cancer patients related to increased risk of distant metastases and tumor recurrence.Role of human papillomavirus in oropharyngeal squamous cell carcinoma: A review.Counseling the patient with potentially HPV-related newly diagnosed head and neck cancerClinical and scientific impact of human papillomavirus on head and neck cancer.Lessons from Australia: human papillomavirus is not a major risk factor for esophageal squamous cell carcinoma.HPV-associated head and neck cancer: a virus-related cancer epidemic.Strategies to promote translational research within the European Organisation for Research and Treatment of Cancer (EORTC) Head and Neck Cancer Group: a report from the Translational Research SubcommitteeRecent advances in managing human papillomavirus-positive oropharyngeal tumors.Association of combined p73 and p53 genetic variants with tumor HPV16-positive oropharyngeal cancer.The relationship between oral squamous cell carcinoma and human papillomavirus: a meta-analysis of a Chinese population (1994-2011).Human papillomavirus-16 infection in advanced oral cavity cancer patients is related to an increased risk of distant metastases and poor survival.Human papillomavirus predicts outcome in oropharyngeal cancer in patients treated primarily with surgery or radiation therapyActivation of Akt at T308 and S473 in alcohol, tobacco and HPV-induced HNSCC: is there evidence to support a prognostic or diagnostic role?Impact of HPV in Oropharyngeal Cancer.Differential outcome of concurrent radiotherapy plus epidermal growth factor receptor inhibitors versus radiotherapy plus cisplatin in patients with human papillomavirus-related head and neck cancer.Valosin-containing protein (VCP/p97)-expression correlates with prognosis of HPV- negative oropharyngeal squamous cell carcinoma (OSCC)Immune suppression in head and neck cancers: a reviewImproved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.Identification of biomarkers that distinguish human papillomavirus (HPV)-positive versus HPV-negative head and neck cancers in a mouse model.A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer.Novel biomarker panel predicts prognosis in human papillomavirus-negative oropharyngeal cancer: an analysis of the TAX 324 trial.The clinical impact of HPV tumor status upon head and neck squamous cell carcinomas.Hypoxia inducible factor-1 alpha expression is increased in infected positive HPV16 DNA oral squamous cell carcinoma and positively associated with HPV16 E7 oncoproteinPotential impact of human papilloma virus on survival of basaloid squamous carcinoma of the head and neck.Development of HPV vaccines for HPV-associated head and neck squamous cell carcinoma.
P2860
Q24630128-5D8EB6B1-0A7C-4667-93AD-F1C967E1CE7BQ26824925-5E5CDF4E-ECC0-45DB-BCF1-3E3FA15D3C71Q26853669-2355A901-CCA5-4DAB-AE04-62BDADC74D76Q26996504-9DA3FA8A-4591-4C55-B474-1F5B3DF30EE0Q27009209-7C2C5CEE-A281-4D2F-BD88-233ECAEF2C5EQ27024764-B76C6812-B665-48B5-81C4-AB34E2E80C34Q30249150-FD072FBC-AB68-4EAB-BB1B-A0B07A8D6F3EQ30252081-883B81E5-9136-46CC-8600-FCCC6B77E3BCQ31132352-C9602DF4-2BEC-45E2-A483-625AE2913EDAQ33280921-FE1963B1-4285-4BF1-83C9-E0B38F207067Q33568275-DB68296E-B49F-4FA8-ACED-8E636FED576CQ33570512-F8741DB8-4DF5-487C-9E1B-ABE64AFCD095Q33610394-B8BE2787-8B6C-4680-B066-3676209CDF44Q33611458-DA4D960E-5C32-4C98-8D2E-EFFBBE77BEF9Q33626377-56631D04-B842-4528-9EFE-3A39EDE63524Q33658257-D976001B-4AFA-4A13-8E4D-C73773C1A5BDQ33770030-F7948D7E-3E93-4E22-A95E-4B9FA04C70E7Q33908473-E92EEBFA-01F3-4B75-85D9-F615A1DD9CF7Q34031281-75A7A7E0-74AF-48DE-AABD-DE8D69560043Q34064235-DD7E52A6-B9CE-4AE8-80BF-CD71E64D2E54Q34114152-AC61814D-80BB-4023-940C-266F0B9DEDEAQ34160540-58094CBA-4D6B-4CB5-942C-057F53D586C9Q34167611-AB6FD270-C910-4B96-9B99-06A995203B9BQ34241885-7545C334-9F1D-41FE-804B-D0CAB2D1B9C7Q34263251-44AD876C-FFEE-4731-B5AA-718DB4AB7CE5Q34342397-F1B78A77-C45E-425A-939C-D58CF1A87136Q34344038-65011A64-20B9-4BAA-BC58-5BBD019A79A3Q34410251-A9133AC9-B079-47F3-B259-352BB39DC149Q34479115-12D35A16-3264-47AF-8E96-E8BD416EA075Q34554185-F2195581-4C91-4BFD-A1DC-AB7DD9669D7AQ34612282-4835518D-09B5-4682-BD7F-FD0C91C4D516Q34700675-BC7FDECB-D33D-41F5-B7AE-BADE5B3FF5C4Q34749494-FCB8FBE9-D39D-4DC9-9446-F990B04DF1C6Q35080500-E0345E87-1578-41EA-95A5-AC169AC57738Q35169110-BB822B04-E68B-4CF8-B71B-B64ED6DA50FDQ35174609-737D4AC1-9CD3-4942-BEED-817E13BE016FQ35344832-7413EF7C-C224-4187-8DD9-6812812DA3BBQ35541384-F69CA6BF-0E29-4681-BAFE-DF33B524F9B2Q35550280-89AC8688-C258-456A-A8F1-AE9A6B3C6815Q35552591-FF0F3B8C-A0F4-4929-95E1-C9DB964303CD
P2860
Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Human papillomavirus positive ...... up of head and neck carcinoma.
@en
Human papillomavirus positive ...... up of head and neck carcinoma.
@nl
type
label
Human papillomavirus positive ...... up of head and neck carcinoma.
@en
Human papillomavirus positive ...... up of head and neck carcinoma.
@nl
prefLabel
Human papillomavirus positive ...... up of head and neck carcinoma.
@en
Human papillomavirus positive ...... up of head and neck carcinoma.
@nl
P2093
P2860
P1433
P1476
Human papillomavirus positive ...... up of head and neck carcinoma.
@en
P2093
P2860
P304
P356
10.1002/1097-0142(20010815)92:4<805::AID-CNCR1386>3.0.CO;2-9
P407
P577
2001-08-01T00:00:00Z